Interpreting wasted ventilation in EIT assessment of pulmonary embolism: ventilation-weighted high-V/Q burden versus perfusion-defect burden Authors: Chenyi Di, Yun Long, Huaiwu He Published: 2026 Main text We read with great interest the translational study by Rodrigues and colleagues [1] evaluating electrical impedance tomography (EIT) for detecting perfusion defects in pulmonary embolism (PE). By combining experimental pulmonary vascular occlusion, dynamic contrast-enhanced computed tomography (DCE-CT), computed tomography pulmonary angiography (CTPA) clot-burden analysis, non-occlusive control models, and clinical validation, the authors move bedside EIT ventilation/perfusion (V/Q) assessment beyond illustrative imaging toward a testable diagnostic framework. Their regionalized Model 2 is particularly useful because it improves recognition of focal high-V/Q clusters that may be diluted in a purely global analysis. The key interpretative issue is not whether the wasted-ventilation index (WVI) is valuable, but what it measures. We suggest that WVI should be understood primarily as a ventilation-weighted high-V/Q phenotype score, rather than as a direct measure of total perfusion-defect burden. This distinction matters because the study title and diagnostic framing could otherwise encourage readers to equate a high-V/Q functional score with the anatomical or spatial burden of pulmonary arterial obstruction. This work also builds on earlier saline-contrast EIT assessment of PE. In a prospective observational study, functional regions were classified as only ventilated, only perfused, or both ventilated and perfused, and the EIT-derived dead-space percentage showed good diagnostic performance for PE in acute respiratory failure [2]. The accompanying editorial emphasized this approach as a step toward bedside monitoring of regional V/Q matching [3]. Rodrigues et al. substantially strengthen this concept by adding procedurally confirmed vascular occlusion, comparison with DCE-CT and CTPA-derived clot burden, bronchial-obstruction controls, and a weighted regional diagnostic model [1]. The main advance is therefore a more rigorously validated and specificity-oriented refinement of the same physiological target: ventilation delivered to regions with reduced perfusion. According to the authors’ definition, WVI quantifies, within a region of interest (ROI), the proportion of ventilation directed to mostly ventilated pixels, defined by V/Q > 2.0, relative to the total ventilation received by that ROI [1]. This construct has clear physiological meaning because it captures the dead-space-like consequence of vascular obstruction. However, it is not interchangeable with the spatial extent or intensity of perfusion defects. A small hypoperfused region receiving substantial ventilation may generate a prominent WVI signal, whereas a larger hypoperfused region accompanied by atelectasis, consolidation, edema, infarction, or airway closure may contribute less because ventilation is also reduced. WVI should therefore be interpreted as a PE-like high-V/Q phenotype score, not as a direct surrogate for anatomical thrombus burden or total perfusion-defect burden. This distinction clarifies both the strength and the limitation of the authors’ approach. EIT cannot directly identify thrombus; it detects functional consequences of altered regional ventilation and perfusion. A ventilation-weighted high-V/Q metric is an elegant way to avoid classifying matched low-V/low-Q impairment as PE-positive and thereby improve specificity. However, this choice may narrow the diagnostic window. PE-associated regions may therefore become less visible to WVI when ventilation is simultaneously reduced by accompanying parenchymal or airway abnormalities. Such concomitant ventilation impairment is not uncommon in clinical PE or in critically ill patients with suspected PE; therefore, a low or negative WVI does not necessarily exclude a clinically relevant perfusion defect. Conversely, small perfusion defects in well-ventilated lung units may be amplified because of their large ventilation share. These considerations do not weaken WVI as a PE-like high-V/Q score, but they define what the metric is designed to measure and how low or negative values should be interpreted. The bronchial-obstruction and hypoxic pulmonary vasoconstriction (HPV) control model is informative in this regard. We agree that matched low-V/low-Q impairment is an appropriate challenging control for a PE-specific high-V/Q diagnostic model. For a model designed to identify lung units that remain ventilated despite reduced perfusion, not classifying these regions as PE-positive improves specificity. In real critically ill patients, however, matched hypoventilation–hypoperfusion and non-ventilated, non-perfused (NVNP) compartments may arise from multiple mechanisms, including HPV, airway obstruction, consolidation, pleural effusion, infarction, edema, or severe regional derecruitment [4–7]. These regions are not simply “negative” from a broader V/Q-assessment perspective. They may be relevant to gas-exchange impairment, recruitment potential, treatment response, and prognosis; in selected cases, they may also coexist with or obscure PE-related perfusion defects. This issue is clinically relevant because conventional EIT V/Q mapping may leave non-functional lung regions unclassified when both ventilation and perfusion fall below selected thresholds. In a recently accepted imaging report [11], CT-derived lung boundaries were used to provide an anatomical reference for conventional EIT V/Q mapping and to delineate an NVNP compartment, which spatially corresponded to extensive right-lung parenchymal abnormalities on CT and reduced right pulmonary arterial opacification on CTPA. This example illustrates that matched absence of ventilation and perfusion may carry pathophysiological information, rather than merely representing a category to be excluded from PE classification. Accordingly, future EIT V/Q reporting may benefit from separating three complementary constructs: high-V/Q wasted-ventilation burden, reflecting PE-like dead-space physiology; perfusion-defect burden, preferably referenced to an anatomical lung ROI or expected regional perfusion distribution; and matched low-V/low-Q or NVNP burden, representing a distinct critical-care lung phenotype. This separation is consistent with current expert recommendations that contrast-enhanced EIT can detect PE-related regional perfusion defects and V/Q mismatches of different etiologies, while novel or non-standard EIT measures require clear definition and cautious interpretation [8]. It is also consistent with the current reality that EIT-derived V/Q remains mainly relative unless further calibration or cardiac-output information is available [9, 10]. In summary, Rodrigues et al. provide strong evidence that EIT-derived WVI and regionalized Model 2 can identify PE-like high-V/Q phenotypes at the bedside [1]. Explicitly distinguishing ventilation-weighted high-V/Q burden from perfusion-defect burden and NVNP burden would not weaken their diagnostic model. Rather, it may help extend interpretation from binary PE assistance toward severity assessment, treatment-response monitoring, and risk phenotyping in complex critically ill patients. Acknowledgements During the preparation of this manuscript, the authors used ChatGPT (OpenAI) for language editing. The authors reviewed and edited all output and take full responsibility for the final content. Abbreviations Computed tomography Computed tomography pulmonary angiography Dynamic contrast-enhanced computed tomography Electrical impedance tomography Hypoxic pulmonary vasoconstriction Non-ventilated, non-perfused Pulmonary embolism Region of interest Ventilation/perfusion Wasted-ventilation index Author contributions C.D. and H.H. conceived the commentary. C.D. wrote the main manuscript text. Y.L. and H.H. contributed to conceptual framing and interpretation of the referenced studies. H.H. and Y.L. critically revised the manuscript. All authors reviewed and approved the final version. Funding This work was supported by the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2025-JKCS-01), and the National High Level Hospital Clinical Research Funding (2025-PUMCH-A-203). Data availability No datasets were generated or analyzed during the current study. Declarations Ethics approval and consent to participate Not applicable. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement No datasets were generated or analyzed during the current study.